Table 3.

Absolute change of patients' T-scores from baseline

	Exemestane		Anastrozole		p value*
	N	Mean % change (95% CI)	N	Mean % change (95% CI)
At 2 years
Hip
Baseline T-score ≥−2.0	83	−0.16 (−0.29 to −0.03)	80	−0.16 (−0.27 to −0.05)	0.98
Baseline T-score <−2.0	61	0.12 (−0.06 to 0.31)	55	0.01 (−0.19 to 0.21)	0.41
Lumbar spine
Baseline T-score ≥−2.0	87	−0.11 (−0.24 to 0.03)	77	−0.20 (−0.34 to −0.06)	0.35
Baseline T-score <−2.0	63	0.17 (−0.02 to 0.36)	57	0.24 (0.07 to 0.41)	0.61
At 1 year
Hip
Baseline T-score ≥−2.0	97	−0.03 (−0.13 to 0.07)	111	−0.12 (−0.21 to −0.04)	0.18
Baseline T-score <−2.0	61	0.04 (−0.10 to 0.80)	66	0.05 (0.00 to 0.11)	0.89
Lumbar spine
Baseline T-score ≥−2.0	99	−0.08 (−0.18 to 0.02)	111	−0.21 (−0.33 to −0.09)	0.11
Baseline T-score <−2.0	69	0.29 (0.17 to 0.40)	66	0.18 (0.08 to 0.28)	0.18

^*Based on two-sided Student's t test of individual patient change.